Slate Belt Optical & Hearing Center, Llc | |
352 Blue Valley Dr, Bangor, PA 18013-1515 | |
(610) 588-5665 | |
(610) 588-3383 |
Full Name | Slate Belt Optical & Hearing Center, Llc |
---|---|
Type | Facility |
Speciality | Technician/technologist - Optician |
Location | 352 Blue Valley Dr, Bangor, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194885053 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Slate Belt Optical & Hearing Center, Llc 352 Blue Valley Dr, Bangor, PA 18013-1515 Ph: (610) 588-5665 | Slate Belt Optical & Hearing Center, Llc 352 Blue Valley Dr, Bangor, PA 18013-1515 Ph: (610) 588-5665 |
News Archive
Monash University researchers have discovered that the devastating bacterial superbug Clostridioides difficile hijacks the human wound healing system in order to cause serious and persistent disease, opening up the development of new therapies to treat the disease.
Maxygen, Inc. today announced that it has been advised by the Biomedical Advanced Research and Development Authority (BARDA) that Maxygen's proposal for the development of its MAXY-G34 product candidate as a potential medical countermeasure for Acute Radiation Syndrome (ARS) will not be considered for a contract award.
Type 1 diabetes, or T1D, is an autoimmune disease in which the body's immune cells -; led by inflammatory macrophages -; attack and destroy the beta cells of the pancreas that produce insulin.
NovaSterilis Inc. a leader in the development and commercialization of supercritical carbon dioxide (SCCO2) technology in collaboration with CC Chu Ph.D (Cornell) reports successful findings from research funded by a National Institutes of Health (NIH) phase l grant. These results meet the study goal to sterilize absorbable sutures to a sterility assurance level 10-6 (SAL6) without chemical or mechanical degradation. NovaSterilis intends to apply for phase II funding to develop the process ready for commercial application.
› Verified 1 days ago